Role of Genetic Polymorphisms in the Angiogenesis Pathway and Non-small-Cell Lung Cancer Tumor Behavior: Implications in Risk Assessment and Clinical Outcome-Reference-Cited by-同舟云学术

Role of Genetic Polymorphisms in the Angiogenesis Pathway and Non-small-Cell Lung Cancer Tumor Behavior: Implications in Risk Assessment and Clinical Outcome

Published:2013 Issue: Volume: Page:381-403
ISSN:
Container-title:Biochemical Basis and Therapeutic Implications of Angiogenesis
language:
Short-container-title:

Author:

de Mello Ramon Andrade,Luis Michael,Araújo António,Reis Rui Manuel,Hespanhol Venceslau

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4614-5857-9_20

Reference122 articles.

1. Alberg A, Brock M, Samet J (2005) Epidemiology of lung cancer: looking to the future. J Clin Oncol 23:3175–3185

2. Lopez A, Collishaw N, Piha T (1994) A descriptive model of the cigarette epidemic in developed countries. Tob Control 3:242–247

3. Asmis TR, Ding K, Seymour L et al (2008) Age and comorbidity as independent prognostic factors in the treatment of non-small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 26:54–59

4. Brundage M, Davies D, Mackillop W (2002) Prognostic factors in non-small cell lung cancer. Chest 122:1037–1057

5. de Mello RA, Marques DS, Medeiros R, Araújo AM (2011) Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies. World J Clin Oncol 2:367–376

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TheVEGFR2,COX-2andMMP-2polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer;International Journal of Cancer;2015-06-03

2. EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer;Pharmacogenomics;2013-11

3. The Impact of Polymorphic Variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the Risk and Prognosis of Portuguese Patients with Non-Small Cell Lung Cancer;PLoS ONE;2013-09-06